Broadwood Partners Boosts STAA Stake to 21.5%, Now Owns 10.7M Shares

TL;DR

**Broadwood Partners just upped its STAA stake to 21.5%, signaling potential activist moves.**

AI Summary

Broadwood Partners, L.P. filed an Amendment No. 31 to their Schedule 13D, indicating a significant change in their beneficial ownership of STAAR Surgical Company (STAA) common stock. As of January 4, 2024, Broadwood Partners, L.P. now beneficially owns 10,768,430 shares, representing 21.5% of STAAR Surgical's outstanding common stock. This substantial holding gives Broadwood significant influence over company decisions, which matters to investors as it could lead to strategic shifts or increased shareholder activism.

Why It Matters

Broadwood Partners, a known activist investor, increasing its stake to 21.5% could signal an intent to exert more control over STAAR Surgical's strategic direction, potentially leading to changes in management, operations, or even a sale of the company.

Risk Assessment

Risk Level: medium — Increased activist investor ownership can lead to volatility as the market reacts to potential corporate changes, but it can also unlock shareholder value.

Analyst Insight

A smart investor would closely monitor future filings and news from both Broadwood Partners and STAAR Surgical Company for any indications of strategic changes or activist demands, as this significant stake could lead to substantial shifts in company direction or valuation.

Key Numbers

• 10,768,430 — shares beneficially owned (total shares of STAAR Surgical Company held by Broadwood Partners, L.P.)
• 21.5% — percentage of class (Broadwood Partners, L.P.'s ownership percentage of STAAR Surgical Company's common stock)
• $0.01 — par value per share (par value of STAAR Surgical Company's common stock)

Key Players & Entities

• Broadwood Partners, L.P. (company) — the reporting person and activist investor
• STAAR Surgical Company (company) — the issuer of the securities
• Neal C. Bradsher (person) — contact person for Broadwood Capital, Inc.
• January 4, 2024 (date) — date of event requiring the filing
• Delaware (company) — place of organization for Broadwood Partners, L.P.

Forward-Looking Statements

• Broadwood Partners, L.P. will seek to appoint new board members to STAAR Surgical Company. (STAAR Surgical Company) — medium confidence, target: within 6-12 months
• STAAR Surgical Company's stock price will experience increased volatility due to activist investor involvement. (STAAR Surgical Company) — high confidence, target: within 3 months

FAQ

Key Financial Figures

• $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti
• $31.84 — Price ($) 11/28/23 Purchase 91,944 $31.84 (1) 11/28/23 Purchase 5,040 $32.00
• $32.0034 — $31.84 (1) 11/28/23 Purchase 5,040 $32.0034 (2) 11/29/23 Purchase 157,473 $31.
• $31.3763 — 0034 (2) 11/29/23 Purchase 157,473 $31.3763 (3) 11/29/23 Purchase 2,827 $31.99
• $31.9908 — 1.3763 (3) 11/29/23 Purchase 2,827 $31.9908 (4) 11/30/23 Purchase 177,707 $31.
• $31.4207 — 9908 (4) 11/30/23 Purchase 177,707 $31.4207 (5) 1/03/24 Purchase 6,573 $28.928
• $28.928 — 31.4207 (5) 1/03/24 Purchase 6,573 $28.928 (6) 1/04/24 Purchase 63,246 $28.90
• $28.9059 — 28.928 (6) 1/04/24 Purchase 63,246 $28.9059 (7) 1/05/24 Purchase 156,634 $28.4
• $28.4762 — .9059 (7) 1/05/24 Purchase 156,634 $28.4762 (8) 1/05/24 Purchase 100 $28.895
• $28.895 — $28.4762 (8) 1/05/24 Purchase 100 $28.895 1/08/24 Purchase 4,042 $27.1019 (9
• $27.1019 — 00 $28.895 1/08/24 Purchase 4,042 $27.1019 (9) (1) This constitutes the weighted
• $31.00 — e purchase price. The prices range from $31.00 to $31.9998. The Reporting Person will
• $31.9998 — price. The prices range from $31.00 to $31.9998. The Reporting Person will provide upon
• $32.00 — e purchase price. The prices range from $32.00 to $32.01. The Reporting Person will pr
• $32.01 — price. The prices range from $32.00 to $32.01. The Reporting Person will provide upon

Filing Documents

• d10931167_13d-a.htm (SC 13D/A) — 107KB
• 0000919574-24-000295.txt ( ) — 108KB

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 10, 2024 Broadwood Partners, L.P.* By: Broadwood Capital, Inc. By: /s/ Neal C. Bradsher Name: Neal C. Bradsher Title: President Broadwood Capital, Inc. * By: /s/ Neal C. Bradsher Name: Neal C. Bradsher Title: President /s/ Neal C. Bradsher Neal C. Bradsher * * This Reporting Person disclaims beneficial ownership over the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A JOINT FILING AGREEMENT The undersigned agree that this Amendment No. 31 to Schedule 13D, dated January 10, 2024, relating to the Common Stock, par value $0.01 per share, of STAAR Surgical Company shall be filed on behalf of the undersigned. Dated: January 10, 2024 Broadwood Partners, L.P. By: Broadwood Capital, Inc. By: /s/ Neal C. Bradsher Name: Neal C. Bradsher Title: President Broadwood Capital, Inc. By: /s/ Neal C. Bradsher Name: Neal C. Bradsher Title: President /s/ Neal C. Bradsher Neal C. Bradsher Exhibit B Schedule of Transactions in the Shares Trade Date Purchase/Sale/Gift Quantity Price ($) 11/28/23 Purchase 91,944 $31.84 (1) 11/28/23 Purchase 5,040 $32.0034 (2) 11/29/23 Purchase 157,473 $31.3763 (3) 11/29/23 Purchase 2,827 $31.9908 (4) 11/30/23 Purchase 177,707 $31.4207 (5) 1/03/24 Purchase 6,573 $28.928 (6) 1/04/24 Purchase 63,246 $28.9059 (7) 1/05/24 Purchase 156,634 $28.4762 (8) 1/05/24 Purchase 100 $

View Full Filing

View this SC 13D/A filing on SEC EDGAR